Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-021521
Filing Date
2025-08-12
Accepted
2025-08-12 19:57:57
Documents
1
Period of Report
2025-08-11

Document Format Files

Seq Description Document Type Size
1 form4-08122025_110854.html 4  
1 form4-08122025_110854.xml 4 7748
  Complete submission text file 0001415889-25-021521.txt   9224
Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD, #200 SOUTH SAN FRANCISCO CA 94080
Business Address
Peetz Christopher (Reporting) CIK: 0001614740 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38981 | Film No.: 251208540